Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Upgrades Royal Gold (RGLD) to Buy
-
Horizon Pharma (HZNP) PT Raised to $36 at Cantor Fitzgerald
-
EPAM Systems (EPAM) PT Raised to $219 at Cantor Fitzgerald
-
Fiserv (FISV) PT Raised to $110 at Cantor Fitzgerald
-
Tabula Rasa Healthcare (TRHC) PT Lowered to $85 at Cantor Fitzgerald
-
Puma Biotechnology (PBYI) PT Lowered to $14 at Cantor Fitzgerald
-
EVO Payments (EVOP) PT Lowered to $28 at Cantor Fitzgerald
-
Stable Road Acquisition Corp. (SRAC) Prices 15M Share Unit IPO at $10/Unit
-
Stable Road Acquisition Corp. Announces Pricing of $150,000,000 Initial Public Offering
-
Stable Road Acquisition Corp. Announces Pricing of $150,000,000 Initial Public Offering
-
Cantor Fitzgerald Starts CV Sciences (CVSI) at Overweight
-
Cantor Fitzgerald Starts Charlotte's Web Holdings (CWBHF) at Neutral
-
Cantor Fitzgerald Starts cbdMD Inc. (YCBD) at Neutral
-
Cantor Fitzgerald Upgrades Hecla Mining (HL) to Spec. Buy
-
Freddie Mac Prices $739 Million Multifamily K-Deal, K-F71
-
Virtu Financial Launches Virtu Capital Markets to Provide At-The-Market Offerings to Corporate Issuers
-
Aerie Pharma (AERI) PT Lowered to $30 at Cantor Fitzgerald
-
Globus Medical (GMED) PT Raised to $64 at Cantor Fitzgerald
-
AxoGen, Inc. (AXGN) PT Lowered to $19 at Cantor Fitzgerald
-
Evolus (EOLS) Prices 5.217M Share Common Offering at $13/Sh
-
Evolus Announces Pricing of Public Offering of Common Stock
-
Stocks, dollar rally on U.S.-China trade deal hopes
-
Evolus (EOLS) Announces Proposed Public Offering of Common Stock
-
Evolus Announces Proposed Public Offering of Common Stock
-
Celebrities play with purpose at 5th Annual LAPMF Heroes for Heroes Celebrity Poker Tournament
-
Cantor Fitzgerald Downgrades Excellon Resources (EXN:CN) (EXLLF) to Hold
-
ANI Pharmaceuticals (ANIP) PT Lowered to $78 at Cantor Fitzgerald
-
CVS Health (CVS) PT Raised to $85 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on MannKind (MNKD)
-
Amarin Corporation (AMRN) Beats but Vascepa Remains Underappreciated - Cantor
-
Regeneron Pharma (REGN) PT Lowered to $400 at Cantor Fitzgerald
-
Zimmer Biomet (ZBH) PT Raised to $160 at Cantor Fitzgerald
-
Computer Programs and Systems (CPSI) PT Raised to $27 at Cantor Fitzgerald
-
GW Pharma (GWPH) PT Lowered to $174 at Cantor Fitzgerald
-
FinServ Acquisition Corp. Announces Closing of $250,000,000 Initial Public Offering
-
FinServ Acquisition Corp. Announces Closing of $250,000,000 Initial Public Offering
-
Cantor Fitzgerald Starts Aphria Inc. (APHA:CN) (APHA) at Overweight
-
UPDATE: Cantor Fitzgerald Starts OrganiGram Holdings Inc (OGI:CN) (OGI) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Hexo Corp. (HEXO:CN) (HEXO) at Underweight
-
UPDATE: Cantor Fitzgerald Starts Canopy Growth Corp (WEED:CN) (CGC) at Neutral
-
UPDATE: Cantor Fitzgerald Starts Aurora Cannabis (ACB:CN) (ACB) at Neutral
-
UPDATE: Cantor Fitzgerald Upgrades Amgen (AMGN) to Overweight
-
Cantor Fitzgerald Starts Tilray (TLRY) at Neutral
-
Cantor Fitzgerald Downgrades Wright Medical (WMGI) to Neutral, Following Takeover Bid
-
Reata Pharmaceuticals (RETA) PT Raised to $250 at Cantor Fitzgerald
-
HMS Holdings (HMSY) PT Lowered to $40 at Cantor Fitzgerald
-
Cantor Fitzgerald & Co. Hires Paul Mutter as Head of Institutional Client Coverage
-
FinServ Acquisition Corp. (FSRV) Prices 22M Unit IPO at $10/Unit
-
FinServ Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering
-
FinServ Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

